Loading...
Market
First region to administer H5N1 mRNA vaccine by end of 2025?
2
Resolution / Starting Odds
Africa • 25%
Asia • 25%
Latin America • 25%
Other • 25%
WHO official announcements, regional health authority announcements, or press releases
Story
WHO Launches Initiative Today for H5N1 mRNA Vaccine Development
Jul 29, 2024, 11:02 AM
The World Health Organization (WHO) and the Medicines Patent Pool (MPP) have launched a new initiative today to accelerate the development and accessibility of mRNA vaccines for human avian influenza (H5N1). This project aims to support manufacturers in low- and middle-income countries, ensuring they are not left behind in the vaccine distribution queue as seen in past pandemics. The initiative involves a group of emerging vaccine companies working on H5N1 mRNA vaccine candidates.
View original story
Similar markets
Africa • 25%
Asia • 25%
South America • 25%
Other • 25%
Pfizer • 25%
Moderna • 25%
Johnson & Johnson • 25%
Other • 25%
United States • 25%
European Union • 25%
Africa • 25%
Other • 25%
United States • 25%
Canada • 25%
United Kingdom • 25%
Other • 25%
WHO • 25%
CDC • 25%
European Medicines Agency (EMA) • 25%
Other • 25%
United States • 25%
European Union • 25%
China • 25%
Other • 25%
Finland • 25%
Germany • 25%
France • 25%
Spain • 25%
United States • 25%
European Union • 25%
China • 25%
Other • 25%
Europe • 25%
United States • 25%
Asia • 25%
Other • 25%
United States • 25%
European Union • 25%
India • 25%
Other • 25%
USA • 25%
Finland • 25%
Japan • 25%
Other EU country • 25%